Frank Karbe's Net Worth
$3.68 Million
Who is Frank Karbe?
Frank Karbe has an estimated net worth of $3.68 Million. This is based on reported shares across multiple companies, which include Phathom Pharmaceuticals, Inc., EXELIXIS INC, Arbutus Biopharma Corp, Myovant Sciences Ltd., ADURO BIOTECH, INC., and Better Therapeutics, Inc..
SEC CIK
Frank Karbe's CIK is 0001276700
Past Insider Trading and Trends
2020 was Frank Karbe's most active year for acquiring shares with 12 total transactions. Frank Karbe's most active month to acquire stocks was the month of July. 2020 was Frank Karbe's most active year for disposing of shares, totalling 19 transactions. Frank Karbe's most active month to dispose stocks was the month of July. 2024 saw Frank Karbe paying a total of $254,112.50 for 35,500 shares, this is the most they've acquired in one year. In 2020 Frank Karbe cashed out on 84,200 shares for a total of $972,081.15, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $17.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +128.21% | 25K |
$10.16 | $254,112.50 | 44.5K |
May 29
| |||
Form 4
| +116.67% | 10.5K |
—
|
—
| 19.5K |
May 23
| |||
Form 4
|
∞
| 9K |
—
|
—
| 9K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EXELIXIS INC (EXEL) Snapshot price: $25.13
EVP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.18% | 1.1K |
—
|
—
| 93.99K |
Feb 15
| |||
Form 4
| +1.33% | 1.22K |
—
|
—
| 92.89K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 4
| +1.37% | 1.22K |
—
|
—
| 90.52K |
Aug 15
| |||
Form 4
| +1.38% | 1.22K |
—
|
—
| 89.3K |
May 15
| |||
Form 4
| +1.29% | 1.04K |
—
|
—
| 81.79K |
Feb 15
| |||
Form 4
| +1.56% | 1.24K |
—
|
—
| 80.75K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 4
| +1.64% | 1.24K |
—
|
—
| 76.64K |
Aug 15
| |||
Form 4
| +1.67% | 1.24K |
—
|
—
| 75.41K |
May 15
| |||
Form 4
| -5.29% | -4.15K |
—
|
—
| 74.17K |
Feb 15
| |||
Form 4
| +2.56% | 1.95K |
—
|
—
| 78.32K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
| +2.65% | 1.95K |
—
|
—
| 75.76K |
Aug 15
| |||
Form 4
| +2.72% | 1.95K |
—
|
—
| 73.8K |
May 15
| |||
Form 4
| +13.00% | 7.81K |
—
|
—
| 67.92K |
Feb 15
| |||
Form 4
| +37.84% | 16.5K |
$2.98 | $49,165.20 | 60.11K |
Aug 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
| +126.45% | 17.5K |
$3.28 | $57,375.00 | 31.34K |
Oct 30 - Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Principal Fin'l & Accounting
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.50% | -3.23K |
$21.75 | -$70,296.00 | 212.3K |
Jul 7
| |||
Form 4
| +41.43% | 63.14K |
—
|
—
| 215.53K |
Apr 15
| |||
Form 4
| -6.78% | -11.08K |
$18.63 | -$206,420.40 | 152.39K |
Apr 6
| |||
Form 4
|
—
|
0
|
$13.26 | -$12,217.50 | 163.47K |
Scheduled
|
Feb 16
| ||
Form 4
|
—
|
0
|
$14.56 | -$5,667.00 | 163.47K |
Scheduled
|
Jan 28
| ||
Form 4
|
—
|
0
|
$13.31 | -$12,292.50 | 163.47K |
Scheduled
|
Jan 15
| ||
Form 4
|
—
|
0
|
$17.56 | -$293,702.00 | 163.47K |
Scheduled
|
Dec 28
| ||
Form 4
|
—
|
0
|
$14.58 | -$19,997.20 | 327.61K |
Scheduled
|
Dec 15
| ||
Form 4
|
—
|
0
|
$14.56 | -$28,335.00 | 163.47K |
Scheduled
|
Nov 30
| ||
Form 4
|
—
|
0
|
$12.56 | -$11,167.50 | 163.47K |
Scheduled
|
Nov 17
| ||
Form 4
|
—
|
0
|
$12.56 | -$11,167.50 | 163.47K |
Scheduled
|
Nov 13
| ||
Form 4
|
—
|
0
|
$13.42 | -$12,465.00 | 163.47K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
$12.57 | -$369,692.95 | 163.47K |
Scheduled
|
Aug 28 - Aug 31
| ||
Form 4
|
—
|
0
|
$12.56 | -$10,423.00 | 163.47K |
Scheduled
|
Aug 19
| ||
Form 4
| +277.32% | 120.15K |
—
|
—
| 163.47K |
Apr 3
| |||
Form 4
| -31.26% | -19.70K |
$15.55 | -$306,350.55 | 43.32K |
Dec 30
| |||
Form 4
| +687.81% | 55.02K |
—
|
—
| 63.02K |
Aug 26
| |||
Form 4
|
∞
| 8K |
$9.10 | $72,800.00 | 8K |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADURO BIOTECH, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||